FBXO32 and cardiac hypertrophy: Recently Li et al. demonstrated that atrogin‐1 is expressed in heart and inhibits calcineurin‐dependent cardiac hypertrophy by priming calcineurin for ubiquitin‐mediated proteolysis 55.